Philip Morris Trimmed Guidance, But Its Growth Story Looks UnshakenPhilip Morris International NYSE: PM Chief Executive Officer Jacek Olczak said the company has revised its full-year guidance solely to reflect foreign-exchange movements, citing a favorable currency impact of about $0.24 at current spot rates. For the third quarter, the company expects a favorable currency effect of about $0.01, he said during a Barclays discussion hosted by Pallav Mittal, the bank’s head of global tobacco.
Get PM alerts:
Olczak said the company remains focused on expanding its smoke-free product portfolio, led by IQOS heated tobacco products and ZYN nicotine pouches, while combustible cigarette volumes have performed somewhat better than previously expected in certain markets.
Japan tax changes and IQOS performance Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and DoubtJapan remains a key focus as the country implements successive excise-tax-driven price increases. Olczak said an April tax increase was followed by a second stage of increases in October, with another increase expected next April affecting both cigarettes and heated tobacco products.
He acknowledged that the magnitude and frequency of price changes can create “some sort of a shockwave” for consumers, particularly because heated tobacco and cigarettes have faced different pricing dynamics. Still, he said the heated tobacco category has stabilized following consumer inventory loading and deloading ahead of the October increase and is resuming growth.
3 Dividend Kings Outshining the Market in 2025Olczak said Philip Morris continues to target net adjusted in-market sales growth in Japan for the full year. He noted that heated tobacco had exceeded 50% of Japan’s nicotine market by volume about a year ago and that IQOS has maintained a high share of the premium segment despite competitive pricing strategies.
The revised tax framework also improves the economics of price increases for heated tobacco products, according to Olczak. He said Philip Morris was able to pass through the latest Japanese increase “plus,” resulting in margin improvement in the market.
While higher heated-tobacco prices temporarily reduce the financial incentive for cigarette users to switch, Olczak said the competitive pricing relationship should become more balanced when cigarette prices rise as well. He said the company expects Japan’s revenue performance to remain solid even as consumer elasticity affects volume trends.
Growth outlook and U.S. IQOS plans Olczak said Philip Morris views low-double-digit to low-teens earnings-per-share growth as an attainable medium-term objective. The outlook is supported by a shift in the company’s business mix, including what he said could be a sixth consecutive year of total volume growth.
Both combustible and smoke-free categories are contributing pricing growth, he said, while positive volumes are improving the quality of revenue growth. Marketing investments can fluctuate depending on the company’s efforts to establish or strengthen leadership positions in smoke-free categories, he added.
On the U.S. market, Olczak said the company is prepared to launch IQOS ILUMA once it receives authorization from the U.S. Food and Drug Administration. He declined to provide a timeline for the pending premarket tobacco product application, saying only that approval appears “shorter” and “sooner than later.”
Philip Morris has authorization for an earlier IQOS technology, but Olczak said it would not make sense to launch that retired version in the United States while the company awaits authorization for ILUMA. He said the company is also preparing future IQOS innovations beyond ILUMA.
Over time, Olczak said heated tobacco products could reach roughly 10% of the combined U.S. cigarette and heated tobacco market, based on IQOS performance across other markets. He characterized the United States as the company’s largest unaddressed growth opportunity, citing its size and attractive nicotine-product economics.
ZYN expansion targets pouch-market growth In the United States, Philip Morris has expanded ZYN through its ZYN ULTRA line, adding more than 20 stock-keeping units over roughly two months. The expanded offering includes moist-format products and higher nicotine strengths, including 9 milligram and 11 milligram options, compared with the flagship ZYN range of 3 milligrams and 6 milligrams.
Olczak said the company is also considering a 1.5 milligram offering. The broader nicotine-strength range is intended to serve consumers entering the category at lower strengths as well as those seeking stronger products, he said.
The company is transitioning from 15-pouch cans to 20-pouch cans and is adjusting ZYN’s historical price premium to a more manageable level, according to Olczak. He said the changes are designed to provide additional consumer value and support growth and market-share recovery.
Olczak said ZYN ULTRA has been received in line with company expectations, though distribution buildout and consumer communication remain important because of the scale of the portfolio expansion. Philip Morris has also launched a “When It Clicks” campaign and is increasing investment behind the brand during the second half of the year.
Despite recent market data suggesting mid-teens category growth, Olczak said he still expects the U.S. nicotine pouch category to grow at a rate above 20% over the longer term. He said growth is supported by consumers shifting from other oral tobacco products, e-vapor products and cigarettes, though usage patterns differ among those groups.
Capital allocation priorities Olczak said the company’s first capital-return priority remains its dividend and dividend growth. He said Philip Morris expects to discuss the dividend with its board and could begin discussing share repurchases shortly afterward, though he made no commitment on timing or size.
“Dividend is the most preferred form” of returning cash to shareholders, Olczak said, adding that buybacks would be a subsequent consideration absent other investment opportunities.
About Philip Morris International (NYSE:PM)Philip Morris International Inc is a global tobacco and nicotine company headquartered in Stamford, Connecticut. The company develops, manufactures and markets cigarettes, smoke-free products, nicotine products and related consumer offerings in markets around the world.
Its portfolio includes internationally recognized cigarette brands such as Marlboro, Parliament, L&M and Chesterfield. PMI is also expanding beyond traditional cigarettes through heated-tobacco products, including IQOS, e-vapor products such as VEEV, and oral nicotine products including ZYN, which became part of the company's portfolio following its acquisition of Swedish Match.
Philip Morris International was established as an independent company in 2008 after being separated from Altria Group, whose U.S.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Philip Morris International Right Now?Before you consider Philip Morris International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Philip Morris International wasn't on the list.
While Philip Morris International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Philip Morris International zvyšuje celoroční výhled upraveného EPS pro rok 2026 na 8,35 až 8,50 USD, což znamená růst o 10,7 % až 12,7 % proti roku 2025. Reportovaný EPS nyní očekává na 7,28 až 7,43 USD kvůli měnovému vlivu.
Philip Morris International Inc.’s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 Barclays Global Consumer Conference in Boston at 9:45 a.m. ET.
The live webcast will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI’s Investor Relations App at www.pmi.com/irapp.
2026 Full-Year Forecast
PMI raises its 2026 full-year reported diluted EPS forecast to a range of $7.28 to $7.43 to reflect currency only. Excluding a total 2026 adjustment of $1.07 per share, the forecast range for adjusted diluted EPS of $8.35 to $8.50 represents a projected increase of 10.7% to 12.7% versus $7.54 in 2025. Excluding a favorable currency impact, at prevailing exchange rates, of $0.24 per share (previously $0.15), this represents growth of 7.5% to 9.5%. We also update our Q3 adjusted diluted EPS forecast for currency only to a range of $2.29 to $2.34, now including an estimated 1 cent favorable currency impact (previously unfavorable 8 cents).
All other forecast assumptions remain unchanged from those communicated on July 22, 2026.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.
Full-Year
2026
Forecast
2025
Growth
Reported Diluted EPS
$7.28
-
$7.43
$ 7.26
Adjustments
Amortization of intangibles
0.50
0.50
Fair value adjustment for equity investments
0.16
(0.18)
Restructuring charges
0.03
0.14
Income tax impact associated with Swedish Match AB financing
0.06
(0.25)
Non-cash impairment of RBH equity investment
0.33
—
Egypt sales tax settlement adjustment
(0.01)
—
Other 2025 Adjustments (1)
—
0.07
Total Adjustments
1.07
0.28
Adjusted Diluted EPS
$8.35
-
$8.50
$ 7.54
10.7%
-
12.7%
Less: Currency
0.24
Adjusted Diluted EPS, excluding currency
$8.11
-
$8.26
$ 7.54
7.5%
-
9.5%
(1) Includes: $0.10 Germany excise tax classification litigation charge; ($0.10) RBH (Canada) Plan Implementation, including dividend income, net; $0.09 Impairment of Wellness business related equity investment; $0.06 Loss on expected sale of consumer accessories and other businesses; $0.03 Impairment of goodwill; ($0.11) Tax items
Forward-Looking & Cautionary Statements
This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.
PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt our SFP commercialization efforts, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; excise tax increases and discriminatory tax structures; health concerns relating to the use of tobacco and other nicotine-containing products; litigation related to tobacco and/or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; geopolitical instability; the impact and consequences of Russia's invasion of Ukraine; changes in legal-age adult smoker behavior; continued decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; disruptions in the credit markets or changes to its credit ratings; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for its electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful, in key markets or systemically, in its efforts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, and promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to enter new markets or improve its margins through increased prices and productivity gains; if other market participants are more successful in their SFP commercialization efforts; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance.
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2025, and the Quarterly Report on Form 10-Q for the second quarter ended June 30, 2026. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.
Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for approximately 42% of PMI’s second-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for legal age adults who would otherwise smoke or use other nicotine-containing consumer products, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus, ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables, General snus and 20 ZYN nicotine pouch variants also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA in their respective categories. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.
Non-GAAP Measures, Glossary and Explanatory Notes
Reconciliations of non-GAAP measures in this release to the most directly comparable U.S. GAAP measures can be found in Exhibit 99.2 to the Form 8-K dated July 22, 2026, and here. A glossary of key terms, definitions and explanatory notes is available in the aforementioned Exhibit 99.2 and on the same webpage, where additional financial schedules, as well as adjustments and other calculations have also been made available.
Management reviews earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, divestitures, restructuring costs, tax items and other adjusting items. Additionally, starting in 2022 and on a comparative basis, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI’s revenue generation, as well as impairment of intangible assets, if any. While amortization expense on acquisition related intangible assets is excluded, the net revenues generated from these acquired intangible assets are included in the company's adjusted measures, unless otherwise stated. Currency-neutral rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management.
Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with U.S. GAAP.
Philip Morris International ve 2. čtvrtletí poprvé překročil čisté tržby 11 miliard USD a upravený EPS vzrostl na 2,20 USD. Firma zároveň zvýšila výhled růstu EPS pro rok 2026 na 11 % až 13 %.
I've been wrong about Philip Morris International (PM +1.03%) for years. I avoided the stock on the premise that it wasn't a particularly safe ticker given the industry it operates in. But the company has adapted remarkably well, with a growing portfolio of products beyond traditional tobacco, and the numbers are becoming increasingly difficult to ignore.
The stock closed near $192 recently, and has delivered a 137% total return over the past five years, compared with 71% for the S&P 500. Here's what's changed about the company.
Premium Feature
Moneyball Superscore
81/100
Today's Change
(
1.03
%) $
1.94
Current Price
$
189.24
What I got wrong My thesis was simple and lazy. Cigarette volumes have been declining in developed markets, regulators keep tightening, and a tobacco company can't outrun that math. I treated the company as a yield trap that would grind lower while paying me to wait.
What I missed is that Philip Morris wasn't defending cigarettes. It was funding a replacement with cash from cigarette sales. In 2020, smoke-free products made up 24% of total revenue. By the first half of 2026, that figure hit 42%, and management targets more than two-thirds by 2030. More growth is forecast by 2030, but the direction is settled either way.
Image source: Getty Images.
The quarter that changed my read Second-quarter net revenue crossed $11 billion for the first time, up 10.4% reported and 7.6% organically, beating the $10.64 billion consensus by 5.2%. Adjusted EPS came in at $2.20, up 15.2%, topping the $2.05 estimate by 7.4% and marking a fifth consecutive quarterly beat. Adjusted operating income reached $4.8 billion, up 12.4%.
The mix is what convinced me. International smoke-free net revenue grew organically by 13.7% in the first half, with gross profit up 16.9%. That segment's gross margin reached 70%, expanding 190 basis points. These are software-like margins on a physical product, and they now sit on nearly half the revenue base.
What the company is up to IQOS is the engine for the company. Adjusted in-market sales volume grew 5.1% in the quarter, or 10.2% excluding Japan and Poland, where an April excise increase and a flavor ban created transitory drag. IQOS holds roughly 76% of the global heated tobacco category it created, and HTU share stayed stable at 31.8%. Smoke-free products are now available in 108 markets.
ZYN got a regulatory unlock. The FDA granted marketing authorization for 20 ZYN variants during the quarter. United States shipments reached 2.9 billion pouches, up 25% sequentially, with the brand holding 57.1% retail value share. International modern oral shipments grew 32%, excluding the mature Nordic markets. PMI also launched ZYN ULTRA with 9mg and 11mg moist variants.
VEEV is the quiet third leg of the company. E-vapor volume surged 55.1% in the quarter. Total shipments of 205.2 billion units grew 2.5%, and cigarette volumes actually rose 1.1%, which was ahead of expectations.
I think it's time to stop watching from the sidelines with Philip Morris. Management raised 2026 EPS growth guidance to 11% to 13% and reaffirmed 5% to 7% organic revenue growth with 7.5% to 9.5% currency-neutral EPS growth. The company is increasing U.S. investment in ZYN ahead of intensifying competition and preparing the IQOS ILUMA launch.
Three years of 104% returns and five years of 137% didn't happen because of financial engineering. They happened because the company built a higher-margin business within a declining one and reached the point where the new business drives growth. That's a pivot I didn't think was possible, and I was wrong.
At $191.89, the stock is no longer cheap, and some analysts peg total upside near 20.4%, or a 6.6% annualized return, which falls short of what equity risk usually demands. So I'm changing my mind about the business, not claiming the stock is a bargain. Those are different admissions, and only the first one was my mistake.
Ausdal Financial Partners Inc. purchased a new stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 17,510 shares of the company’s stock, valued at approximately $3,168,000.
Other hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC increased its position in Philip Morris International by 31.1% during the fourth quarter. Brighton Jones LLC now owns 8,531 shares of the company’s stock valued at $1,027,000 after acquiring an additional 2,023 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in Philip Morris International by 4.5% in the fourth quarter. Revolve Wealth Partners LLC now owns 2,097 shares of the company’s stock worth $252,000 after purchasing an additional 91 shares during the last quarter. Sivia Capital Partners LLC grew its stake in shares of Philip Morris International by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 5,636 shares of the company’s stock valued at $1,027,000 after purchasing an additional 1,970 shares during the period. Jump Financial LLC bought a new stake in shares of Philip Morris International during the 2nd quarter valued at about $2,454,000. Finally, Osterweis Capital Management Inc. increased its position in shares of Philip Morris International by 2,280.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 357 shares of the company’s stock valued at $65,000 after purchasing an additional 342 shares during the last quarter. 78.63% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets Several equities analysts have recently weighed in on PM shares. Morgan Stanley increased their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday, July 23rd. Weiss Ratings restated a “buy (b)” rating on shares of Philip Morris International in a research report on Monday, August 17th. Citigroup upped their target price on shares of Philip Morris International from $210.00 to $225.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Barclays increased their price target on shares of Philip Morris International from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. Finally, Stifel Nicolaus lifted their price target on shares of Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $205.89.
Get Our Latest Research Report on Philip Morris International Philip Morris International Price Performance PM stock opened at $193.94 on Thursday. Philip Morris International Inc. has a 1-year low of $142.11 and a 1-year high of $207.76. The business has a 50 day simple moving average of $186.71 and a two-hundred day simple moving average of $178.64. The company has a market capitalization of $302.28 billion, a price-to-earnings ratio of 27.86, a PEG ratio of 2.34 and a beta of 0.38.
Philip Morris International (NYSE:PM – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.05 by $0.15. The firm had revenue of $11.19 billion for the quarter, compared to analysts’ expectations of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. Sell-side analysts anticipate that Philip Morris International Inc. will post 8.33 EPS for the current fiscal year.
Philip Morris International Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Thursday, June 25th were issued a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s dividend payout ratio is 84.48%.
Philip Morris International Company Profile (Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
Featured Stories Five stocks we like better than Philip Morris International Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise Alcoa’s Gallium Project Opens a New Door Beyond Aluminum Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech Can Tesla’s Flying Roadster Distract From Its Real Risks? Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM – Free Report).
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
Key Takeaways Philip Morris won FDA marketing authorization for 11 ZYN ULTRA nicotine pouch products in the United States.ZYN ULTRA approvals cover all 9mg variants and one 11mg Smooth variant, with more 11mg products under review.PM's smoke-free products span 109 markets and generated roughly 42% of second-quarter 2026 net revenues. Philip Morris International Inc. PM continues to advance its smoke-free transformation, with regulatory progress in the United States adding another potential growth lever. The FDA has authorized Swedish Match USA, Inc., a U.S. affiliate of Philip Morris International, to market 11 ZYN ULTRA moist oral nicotine pouch products following scientific review, broadening the company’s presence in the U.S. nicotine pouch category.
The authorizations cover all 9mg ZYN ULTRA variants and one 11mg Smooth variant, while additional 11mg products remain under FDA review. ZYN ULTRA, which has higher moisture content than the flagship ZYN range, is free of tobacco leaf. The latest action builds on earlier FDA authorizations for ZYN’s 3mg and 6mg variants and broadens Philip Morris’ portfolio of smoke-free alternatives for legal-age nicotine consumers.
The development broadens Philip Morris’ ability to serve legal-age nicotine consumers with a wider range of smoke-free alternatives. ZYN ULTRA also extends the brand into higher-strength offerings, potentially improving its reach across different consumer preferences. Philip Morris began commercializing ZYN ULTRA in June 2026 under recent FDA guidance, making the latest authorization an important regulatory step for the expanded range.
The decision adds to a series of FDA actions involving Philip Morris’ smoke-free portfolio. Earlier, 20 ZYN nicotine pouch variants received Modified Risk Tobacco Product authorizations. Versions of IQOS devices and consumables, along with General snus, have also received FDA marketing authorizations, highlighting the company’s growing regulatory footprint across smoke-free categories.
Overall, the ZYN ULTRA authorization reinforces Philip Morris’ long-term push to shift its portfolio toward smoke-free products. With the smoke-free products available across 109 markets and its smoke-free business accounting for roughly 42% of second-quarter 2026 net revenues, continued regulatory progress in the United States could support broader portfolio expansion and strengthen the company’s position in the smoke-free category.
Philip Morris’ Zacks Rank & Share Price PerformanceShares of this Zacks Rank #3 (Hold) company have fallen 2.5% over the past month against the broader Consumer Staples sector and the S&P 500 index’s growth of 2.2% and 3.8%, respectively. PM has outperformed the industry’s decline of 5.2% in the same period.
PM Stock's Past Month Performance
Image Source: Zacks Investment Research
Is PM a Value Play Stock?Philip Morris currently trades at a forward 12-month P/E ratio of 21.22, which is up from the industry average of 15.16 and the sector average of 17.32. This valuation positions the stock at a premium relative to both its direct peers and the broader consumer staples sector.
PM P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to ConsiderThe Chefs' Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East and Canada. At present, CHEF flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Chefs' Warehouse’s current fiscal-year sales and earnings implies growth of 10.6% and 33.7%, respectively, from the year-ago reported figures. Chefs' Warehouse delivered a trailing four-quarter earnings surprise of 30.4%, on average.
The Vita Coco Company, Inc. (COCO - Free Report) develops, manufactures, markets and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa and the Asia Pacific. COCO currently sports a Zacks Rank #1. The company delivered a trailing four-quarter earnings surprise of 21.9%, on average.
The Zacks Consensus Estimate for Vita Coco’s current fiscal-year sales and earnings indicates growth of 31.6% and 64.7%, respectively, from the year-ago reported numbers.
Darling Ingredients Inc. (DAR - Free Report) develops, produces and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America and internationally. At present, Darling Ingredients holds a Zacks Rank of 2 (Buy). DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.
The consensus estimate for Darling Ingredients’ current fiscal-year sales and earnings implies growth of 11.5% and 926.5%, respectively, from the year-ago figures.
FDA autorizovala 11 nových nikotinových sáčků Philip Morris, včetně 9mg variant Zyn Ultra Citrus, Menthol a Wintergreen. Úřad je označil za méně škodlivé než jiné orální a bezdýmné tabákové produkty.
The U.S. Food and Drug Administration said on Friday it had authorized 11 nicotine pouch products recently launched by Philip Morris (PM.N), citing lower levels of harmful constituents compared with other oral and smokeless tobacco products.
Philip Morris unveiled its higher-strength Zyn Ultra nicotine pouches in June, at prices lower than its flagship Zyn brand, to fend off competition from British American Tobacco's (BATS.L) Velo.
Here are more details:
The latest authorization follows the agency's June approval of 20 variants of the company's Zyn pouches as less harmful than cigarettes.
These pouches, placed under the lip to deliver nicotine, are the fastest-growing nicotine category in the United States.
The newly authorized products include 9 mg Zyn Ultra Citrus, Menthol, and Wintergreen variants made by Philip Morris subsidiary Swedish Match USA.
Last month, Philip Morris reported better-than-expected quarterly earnings and said it would increase investment in Zyn as competition intensifies. However, the tobacco company lowered its annual forecast amid currency headwinds.
Bank of New York Mellon Corp zvýšil ve 2. čtvrtletí podíl v Philip Morris International o 30,9 % na 11 669 878 akcií. Hodnota podílu činila 2,111 miliardy USD.
Bank of New York Mellon Corp increased its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 30.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,669,878 shares of the company’s stock after purchasing an additional 2,755,662 shares during the quarter. Bank of New York Mellon Corp owned about 0.75% of Philip Morris International worth $2,111,198,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. AG Campbell Advisory LLC bought a new position in Philip Morris International in the 4th quarter valued at $25,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Philip Morris International during the second quarter valued at $29,000. Portfolio Resources Advisor Group Inc. acquired a new position in shares of Philip Morris International during the fourth quarter valued at $26,000. Vermillion Wealth Management Inc. boosted its holdings in Philip Morris International by 146.5% in the first quarter. Vermillion Wealth Management Inc. now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 104 shares during the last quarter. Finally, Safe Harbor Fiduciary LLC bought a new position in Philip Morris International in the fourth quarter valued at about $29,000. Institutional investors own 78.63% of the company’s stock.
Philip Morris International Price Performance Shares of PM stock opened at $191.85 on Friday. The stock has a market cap of $299.02 billion, a PE ratio of 27.56, a price-to-earnings-growth ratio of 2.29 and a beta of 0.38. The stock has a 50-day moving average of $185.96 and a 200-day moving average of $178.30. Philip Morris International Inc. has a one year low of $142.11 and a one year high of $207.76.
Philip Morris International (NYSE:PM – Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $2.20 EPS for the quarter, beating the consensus estimate of $2.05 by $0.15. The firm had revenue of $11.19 billion during the quarter, compared to the consensus estimate of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. As a group, research analysts anticipate that Philip Morris International Inc. will post 8.33 earnings per share for the current year. Philip Morris International Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were given a $1.47 dividend. The ex-dividend date was Thursday, June 25th. This represents a $5.88 dividend on an annualized basis and a dividend yield of 3.1%. Philip Morris International’s dividend payout ratio is currently 84.48%.
Wall Street Analyst Weigh In A number of analysts recently commented on PM shares. Morgan Stanley boosted their price objective on Philip Morris International from $200.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Citigroup raised their target price on shares of Philip Morris International from $210.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. BTIG Research set a $221.00 price target on shares of Philip Morris International and gave the stock a “buy” rating in a research report on Friday, July 24th. UBS Group boosted their price target on shares of Philip Morris International from $168.00 to $182.00 and gave the stock a “neutral” rating in a research note on Thursday, July 2nd. Finally, Needham & Company LLC increased their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the company a “buy” rating in a report on Thursday, July 23rd. Ten equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Philip Morris International has a consensus rating of “Moderate Buy” and an average price target of $205.89.
Read Our Latest Report on PM
(Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
Read More Five stocks we like better than Philip Morris International 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM – Free Report).
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
Asahi Life Asset Management ve 2. čtvrtletí nově koupila 4 464 akcií Philip Morris International za zhruba 808 000 USD. Firma zároveň vykázala EPS 2,20 USD a tržby 11,19 miliardy USD za čtvrtletí.
Asahi Life Asset Management CO. LTD. acquired a new position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 4,464 shares of the company’s stock, valued at approximately $808,000.
A number of other hedge funds also recently bought and sold shares of PM. AG Campbell Advisory LLC purchased a new position in shares of Philip Morris International in the fourth quarter worth approximately $25,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Philip Morris International in the 2nd quarter valued at approximately $29,000. Portfolio Resources Advisor Group Inc. purchased a new stake in shares of Philip Morris International in the 4th quarter valued at approximately $26,000. Vermillion Wealth Management Inc. boosted its stake in Philip Morris International by 146.5% in the 1st quarter. Vermillion Wealth Management Inc. now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 104 shares during the period. Finally, Safe Harbor Fiduciary LLC acquired a new position in Philip Morris International in the 4th quarter worth approximately $29,000. 78.63% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth PM has been the topic of several recent analyst reports. Needham & Company LLC boosted their target price on shares of Philip Morris International from $200.00 to $215.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Barclays raised their target price on Philip Morris International from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. Morgan Stanley upped their price target on Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Bank of America reissued a “buy” rating on shares of Philip Morris International in a research note on Thursday, May 21st. Finally, Stifel Nicolaus raised their price objective on Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a research report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $205.89.
Check Out Our Latest Stock Report on Philip Morris International Philip Morris International Price Performance NYSE PM opened at $191.85 on Friday. Philip Morris International Inc. has a fifty-two week low of $142.11 and a fifty-two week high of $207.76. The stock’s 50-day moving average is $185.96 and its two-hundred day moving average is $178.30. The firm has a market cap of $299.02 billion, a P/E ratio of 27.56, a price-to-earnings-growth ratio of 2.29 and a beta of 0.38.
Philip Morris International (NYSE:PM – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $2.20 earnings per share for the quarter, topping analysts’ consensus estimates of $2.05 by $0.15. The business had revenue of $11.19 billion during the quarter, compared to analysts’ expectations of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. Philip Morris International’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities analysts expect that Philip Morris International Inc. will post 8.33 EPS for the current year.
Philip Morris International Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were given a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s payout ratio is currently 84.48%.
(Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
Featured Articles Five stocks we like better than Philip Morris International 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
BlackRock Inc. raised its position in Philip Morris International Inc. (NYSE:PM – Free Report) by 0.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 108,039,522 shares of the company’s stock after purchasing an additional 444,449 shares during the quarter. BlackRock Inc. owned 6.93% of Philip Morris International worth $19,545,430,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in Philip Morris International by 31.1% in the 4th quarter. Brighton Jones LLC now owns 8,531 shares of the company’s stock worth $1,027,000 after buying an additional 2,023 shares during the period. Revolve Wealth Partners LLC boosted its position in Philip Morris International by 4.5% in the 4th quarter. Revolve Wealth Partners LLC now owns 2,097 shares of the company’s stock valued at $252,000 after buying an additional 91 shares during the period. Sivia Capital Partners LLC grew its stake in Philip Morris International by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 5,636 shares of the company’s stock worth $1,027,000 after acquiring an additional 1,970 shares in the last quarter. Jump Financial LLC bought a new position in Philip Morris International in the 2nd quarter worth about $2,454,000. Finally, Osterweis Capital Management Inc. increased its position in shares of Philip Morris International by 2,280.0% during the second quarter. Osterweis Capital Management Inc. now owns 357 shares of the company’s stock worth $65,000 after acquiring an additional 342 shares during the period. Institutional investors own 78.63% of the company’s stock.
Wall Street Analyst Weigh In PM has been the subject of a number of research analyst reports. Stifel Nicolaus lifted their target price on Philip Morris International from $195.00 to $205.00 and gave the company a “buy” rating in a research report on Thursday, July 23rd. UBS Group raised their price target on Philip Morris International from $168.00 to $182.00 and gave the company a “neutral” rating in a research note on Thursday, July 2nd. BTIG Research set a $221.00 price objective on Philip Morris International and gave the company a “buy” rating in a report on Friday, July 24th. Needham & Company LLC upped their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Finally, Morgan Stanley increased their target price on shares of Philip Morris International from $200.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Ten equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Philip Morris International has a consensus rating of “Moderate Buy” and a consensus target price of $205.89.
Get Our Latest Report on Philip Morris International Philip Morris International Price Performance Shares of PM stock opened at $187.77 on Wednesday. The stock’s fifty day moving average price is $185.60 and its 200 day moving average price is $178.12. Philip Morris International Inc. has a 1-year low of $142.11 and a 1-year high of $207.76. The company has a market cap of $292.66 billion, a price-to-earnings ratio of 26.98, a price-to-earnings-growth ratio of 2.30 and a beta of 0.38.
Philip Morris International (NYSE:PM – Get Free Report) last released its earnings results on Wednesday, July 22nd. The company reported $2.20 EPS for the quarter, topping analysts’ consensus estimates of $2.05 by $0.15. The company had revenue of $11.19 billion during the quarter, compared to analysts’ expectations of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. Philip Morris International’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the business earned $1.89 EPS. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. As a group, equities research analysts anticipate that Philip Morris International Inc. will post 8.33 earnings per share for the current year.
Philip Morris International Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Thursday, June 25th were issued a $1.47 dividend. The ex-dividend date of this dividend was Thursday, June 25th. This represents a $5.88 dividend on an annualized basis and a dividend yield of 3.1%. Philip Morris International’s dividend payout ratio is currently 84.48%.
Philip Morris International Company Profile (Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
Featured Stories Five stocks we like better than Philip Morris International The AI Boom Is Turning This Cable Maker Into a Stock to Watch A Star Investor Just Trimmed Amazon—Here’s What It means Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look Home Depot Analysts See a Path to $375 and Beyond Want to see what other hedge funds are holding PM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Philip Morris International Inc. (NYSE:PM – Free Report).
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
BCGM Wealth Management zvýšila ve 2. čtvrtletí podíl ve společnosti Philip Morris International o 15,5 % na 31 288 akcií. Hodnota pozice činila 5,66 milionu USD.
BCGM Wealth Management LLC boosted its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 15.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,288 shares of the company’s stock after purchasing an additional 4,194 shares during the period. Philip Morris International comprises 1.2% of BCGM Wealth Management LLC’s holdings, making the stock its 19th biggest holding. BCGM Wealth Management LLC’s holdings in Philip Morris International were worth $5,660,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. AG Campbell Advisory LLC purchased a new position in shares of Philip Morris International during the fourth quarter valued at $25,000. Portfolio Resources Advisor Group Inc. acquired a new position in shares of Philip Morris International during the fourth quarter valued at about $26,000. Richards Merrill & Peterson Inc. acquired a new position in Philip Morris International during the 4th quarter valued at approximately $28,000. Safe Harbor Fiduciary LLC acquired a new stake in Philip Morris International during the 4th quarter worth about $29,000. Finally, Vermillion Wealth Management Inc. lifted its holdings in shares of Philip Morris International by 146.5% during the first quarter. Vermillion Wealth Management Inc. now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 104 shares during the period. 78.63% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes A number of research firms recently issued reports on PM. Weiss Ratings restated a “buy (b)” rating on shares of Philip Morris International in a research report on Wednesday, May 20th. Morgan Stanley lifted their price target on shares of Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Stifel Nicolaus boosted their price objective on Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. UBS Group raised their price target on shares of Philip Morris International from $168.00 to $182.00 and gave the stock a “neutral” rating in a research note on Thursday, July 2nd. Finally, Bank of America restated a “buy” rating on shares of Philip Morris International in a report on Thursday, May 21st. Ten analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $205.89.
Read Our Latest Analysis on PM
Philip Morris International Trading Up 0.8% Philip Morris International stock opened at $190.40 on Friday. The firm has a market capitalization of $296.76 billion, a P/E ratio of 27.36, a P/E/G ratio of 2.30 and a beta of 0.38. Philip Morris International Inc. has a twelve month low of $142.11 and a twelve month high of $207.76. The stock’s fifty day simple moving average is $185.23 and its 200-day simple moving average is $178.00.
Philip Morris International (NYSE:PM – Get Free Report) last released its earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.05 by $0.15. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The firm had revenue of $11.19 billion during the quarter, compared to analyst estimates of $10.60 billion. During the same period last year, the business posted $1.89 earnings per share. Philip Morris International’s revenue was up 10.4% compared to the same quarter last year. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. Sell-side analysts predict that Philip Morris International Inc. will post 8.33 earnings per share for the current year.
Philip Morris International Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Stockholders of record on Thursday, June 25th were given a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s payout ratio is 84.48%.
Philip Morris International Company Profile (Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
See Also Five stocks we like better than Philip Morris International Is Best Buy the AI Winner Hiding in the Electronics Aisle? Applied Materials Beat Everything but Wall Street’s Expectations for Margins Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBank of America Corp DE Trims Holdings in Frontdoor Inc. $FTDR
NEXT HEADLINE »BIP Wealth LLC Purchases 534 Shares of Eli Lilly and Company $LLY
Amundi v 1. čtvrtletí zvýšila podíl ve společnosti Philip Morris International o 10,5 % na 995 120 akcií. Firma zároveň oznámila zisk na akcii 2,20 USD a tržby 11,19 miliardy USD.
Amundi grew its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 10.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 995,120 shares of the company’s stock after acquiring an additional 94,649 shares during the quarter. Amundi owned about 0.06% of Philip Morris International worth $164,533,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Capital International Investors increased its position in shares of Philip Morris International by 13.7% in the fourth quarter. Capital International Investors now owns 101,377,875 shares of the company’s stock worth $16,262,967,000 after acquiring an additional 12,227,004 shares in the last quarter. Capital Research Global Investors lifted its holdings in shares of Philip Morris International by 25.3% during the 4th quarter. Capital Research Global Investors now owns 54,559,706 shares of the company’s stock valued at $8,751,407,000 after acquiring an additional 11,013,173 shares in the last quarter. Capital World Investors lifted its holdings in shares of Philip Morris International by 2.8% during the 4th quarter. Capital World Investors now owns 132,355,726 shares of the company’s stock valued at $21,230,315,000 after acquiring an additional 3,579,399 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in Philip Morris International by 36.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 9,301,112 shares of the company’s stock worth $1,491,898,000 after purchasing an additional 2,475,204 shares during the period. Finally, Vanguard Group Inc. increased its holdings in Philip Morris International by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 145,262,397 shares of the company’s stock valued at $23,300,088,000 after purchasing an additional 1,793,949 shares in the last quarter. 78.63% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In PM has been the topic of a number of recent research reports. Barclays boosted their price objective on Philip Morris International from $205.00 to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday. BTIG Research set a $221.00 target price on Philip Morris International and gave the company a “buy” rating in a report on Friday, July 24th. Citigroup boosted their price target on Philip Morris International from $210.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday. Stifel Nicolaus upped their price target on Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. Finally, Needham & Company LLC increased their price objective on shares of Philip Morris International from $200.00 to $215.00 and gave the company a “buy” rating in a research report on Thursday, July 23rd. Eleven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $205.89.
Get Our Latest Stock Report on PM
Philip Morris International Stock Performance NYSE:PM opened at $192.12 on Friday. The stock has a market cap of $299.44 billion, a price-to-earnings ratio of 27.60, a price-to-earnings-growth ratio of 2.40 and a beta of 0.38. Philip Morris International Inc. has a one year low of $142.11 and a one year high of $207.76. The business’s 50-day simple moving average is $183.34 and its 200 day simple moving average is $176.67.
Philip Morris International (NYSE:PM – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $2.05 by $0.15. The firm had revenue of $11.19 billion during the quarter, compared to analyst estimates of $10.60 billion. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.Philip Morris International’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.89 EPS. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities research analysts predict that Philip Morris International Inc. will post 8.33 EPS for the current year.
Philip Morris International Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Shareholders of record on Thursday, June 25th were paid a dividend of $1.47 per share. This represents a $5.88 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date was Thursday, June 25th. Philip Morris International’s dividend payout ratio is 84.48%.
Philip Morris International Company Profile (Free Report)
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
See Also Five stocks we like better than Philip Morris International Microsoft Just Flipped the AI Spending Narrative Overnight Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling? Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEMicrosoft’s (MSFT) “Outperform” Rating Reaffirmed at Royal Bank Of Canada
NEXT HEADLINE »Ashton Thomas Securities LLC Takes Position in Hilton Worldwide Holdings Inc. $HLT
Philip Morris International zdvojnásobuje investici do svého kampusu v Coloradu na zhruba 1,2 miliardy USD do roku 2028 kvůli rozšíření výroby Zyn. Závod v Aurora byl otevřen v pondělí.
A woman poses with a cigarette in front of Philip Morris International logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
July 27 (Reuters) - Philip Morris International (PM.N), opens new tab said on Monday it had doubled its planned investment in its Colorado manufacturing campus to about $1.2 billion through 2028, as it expands production capacity for the Zyn nicotine pouch business.
The company in 2024 had initially announced a $600 million investment to build a manufacturing facility for Zyn nicotine pouches in Aurora, which opened on Monday.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The company said the facility produces Zyn nicotine pouches and will support exports to markets across Asia, Latin America and the Caribbean.
Once fully operational, the facility is expected to generate approximately $550 million in annual economic impact and support 1,000 indirect jobs, the company said.
The Marlboro maker added that the Aurora campus joins the company's existing modern nicotine manufacturing operations in Owensboro, Kentucky, and Wilson, North Carolina.
Nicotine pouches are the fastest-growing nicotine product in the U.S., with millions of users, driving sales for Philip Morris and helping fuel the company's growth across smoke-free products including heated tobacco device IQOS and vapes.
The investment comes weeks after the U.S. Food and Drug Administration authorized 20 Zyn nicotine pouches as less harmful than cigarettes, allowing the company to market reduced-risk information compared with cigarettes.
In July, Philip Morris beat second-quarter estimates, helped by strong demand for smoke-free products.
Reporting by Sanskriti Shekhar in Bengaluru; Editing by Maju Samuel
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Philip Morris International potřetí letos snížila celoroční výhled upraveného zisku na akcii na 8,26 až 8,41 USD kvůli konkurenci a kurzovým vlivům. Tržby ve 2. čtvrtletí vzrostly o 10,4 % na 11,19 miliardy USD a překonaly odhady.
Packages of Marlboro cigarettes produced by Philip Morris International are seen at the grocery store in Warsaw, Poland May 29, 2024. REUTERS/Kacper Pempel Purchase Licensing Rights, opens new tab
CompaniesJuly 22 (Reuters) - Philip Morris International (PM.N), opens new tab cut its annual profit forecast for the third time this year on Wednesday, hurt by intensifying competition among tobacco products and negative currency swings.
Shares of the company were down 1% in premarket trading.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The company also said it seeks to invest in its Zyn nicotine pouches following recent regulatory approval.
While U.S. regulators have recently taken a more favorable stance toward nicotine pouches, including allowing certain Zyn products to be marketed as less harmful than cigarettes, increased competition and pricing pressure have raised concerns about PMI's ability to maintain its market-leading position.
The company expects full-year adjusted earnings per share of $8.26 to $8.41, compared with its previous forecast of $8.31 to $8.46.
Philip Morris has been investing heavily to diversify beyond cigarettes, but faces mounting competition in the rapidly growing nicotine pouch category from products such as British American Tobacco's (BATS.L), opens new tab Velo.
The company launched Zyn Ultra, a higher-strength moist pouch variant, in June and priced it below PMI's flagship Zyn products on a per-pouch basis, as the company looks to defend market share.
Its second-quarter revenue rose 10.4% to $11.19 billion, exceeding analysts' estimate of $10.63 billion, according to data compiled by LSEG.
Reporting by Neil J Kanatt in Bengaluru and Emma Rumney in London; Editing by Devika Syamnath
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Philip Morris získal od FDA povolení uvádět na trh 20 variant nikotinových sáčků Zyn jako méně škodlivou alternativu ke kouření. Morgan Stanley i Bank of America následně zvýšily cílové ceny akcie.
Wall Street investors are reportedly flooding back into tobacco stocks, erasing years of ethical boycotts as the industry’s aggressive pivot toward smoke-free products blurs old moral lines.
For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict mandates.
But that taboo is quickly going up in smoke. Tobacco companies generating massive sales from non-combustible alternatives are “rejoining polite society” and earning premium stock market valuations from returning institutional capital, the Wall Street Journal reported Thursday.
Alternative tobacco products have sparked a rethink among investors after nearly a decade of ESG-related concerns. Christopher Sadowski The shift gained fresh momentum when the Food and Drug Administration gave the green light for Philip Morris to market 20 variants of its Zyn nicotine pouches as a less harmful alternative to traditional smoking. The June 30 decision noted a reduced risk of lung cancer, stroke and heart disease for people who use the pouches, which go between one’s gums and cheek but don’t contain tobacco.
The move came just weeks after New York Gov. Kathy Hochul signed a new 75% wholesale tax into law on alternative tobacco products — the so-called “Bro Tax.”
Still, crossing the FDA’s regulatory moat prompted immediate action from major investment banks. Morgan Stanley recently raised its price target on Philip Morris to $200, highlighting the upcoming rollout of Zyn Ultra.
“The developments increase our confidence,” Morgan Stanley analysts wrote in a briefing to clients, adding that they see an increased probability for their $250 bull-case scenario as smoke-free alternatives dominate Philip Morris’ revenue.
Bank of America similarly backed the stock, pushing its target to $209 on high-margin smokeless execution.
British American Toboacco has also been embarking upon a share buyback program in recent months. REUTERS Philip Morris generates about 41% of its sales from non-combustible products, the Journal noted, adding it now trades at a massive 70% premium over rivals still heavily dependent on sales of old-fashioned smokes.
While Philip Morris has captured the premium valuations, rival British American Tobacco, or BATm is executing a sweeping, tech-driven transformation to reclaim market share.
The maker of Lucky Strike and Vuse vapes reportedly plans to eliminate 9,000 global jobs — nearly 19% of its workforce — by outsourcing 3,500 roles to Accenture and deploying artificial intelligence to automate back-office operations.
The workforce cuts aim to harvest $800 million in annual savings by 2028, freeing up capital to aggressively fund BAT’s smokeless product expansion.
Wall Street experts are bullish on tobacco stocks, seeing huge growth potential in alternatives to regular cigarettes and AI-related cost savings. LightRocket via Getty Images Barclays analyst Pallav Mittal noted that the “scale of this workforce reduction is unexpected.”
Nevertheless, the strategic shift keeps analysts bullish.
Experts at Jefferies and UBS recently reiterated buy ratings on BAT, joining a solid majority of Wall Street analysts who rate the stock a strong buy as the firm pushes to double its share of the US oral nicotine market.
As combustible cigarette volumes maintain their decades-long decline, the industry’s rapid evolution appears to be permanently redrawing the boundaries of institutional investing.
“The FDA authorization for Zyn … is a significant positive,” Morgan Stanley analysts concluded in their recent note upgrading the sector. “It provides a clear regulatory pathway and validates the harm reduction potential increasing our confidence in the company’s ability to drive accelerated smoke-free growth.”
FDA schválil Philip Morris prodávat Zyn jako méně rizikový než cigarety. U 20 produktů lze tvrdit, že přechod z cigaret snižuje riziko několika nemocí.
The Food and Drug Administration on Tuesday cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes, giving the tobacco giant a major regulatory win as the Trump administration loosens restrictions on nicotine products.
The decision, first reported by Axios, allows 20 Zyn products to carry a modified-risk claim saying that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Zyn pouches contain nicotine but not tobacco. They are placed between a user's gum and lip and have surged in popularity among conservatives, tech workers and others who promote them as a cleaner alternative to cigarettes and chewing tobacco or a productivity aid.
The FDA decision does not mean Zyn is safe. The agency has said there is no safe tobacco product, that youth should not use tobacco products and that adults who do not use tobacco products should not start.
Still, the order gives Philip Morris a powerful health-related claim for one of the fastest-growing products in the nicotine market, as cigarette sales continue to decline in the U.S. and major tobacco companies invest more heavily in smoke-free products.
President Donald Trump, who backed restrictions on flavored e-cigarettes during his first term, reversed course during the 2024 campaign and promised to "save vaping." Since returning to office, his administration has taken a more industry-friendly approach, including by creating a pathway for some flavored e-cigarettes and nicotine pouches to remain on the market while they undergo FDA review.
The shift has followed heavy lobbying from the tobacco and vaping industries, which have argued that adult smokers need more access to less harmful alternatives to cigarettes.
The White House did not respond to a request for comment.
Zyn has also become a cultural marker in conservative politics. Former Fox News host Tucker Carlson helped popularize the brand on the right before later souring on Zyn and launching his own nicotine pouch brand, Alp.
Nicotine pouches have also gained fans inside Trump's orbit. The Wall Street Journal reported that Health and Human Services Secretary Robert F. Kennedy Jr. uses nicotine pouches and that Trump recently asked Kennedy which pouches he used after a lunch with tobacco executives.
The FDA had already authorized the same 20 Zyn products for sale in January 2025, but that earlier decision did not allow Swedish Match, the subsidiary of Philip Morris that makes Zyns, to market them as reducing disease risk. Tuesday's order goes further by allowing the company to make a specific lower-risk claim tied to several major smoking-related diseases.
"FDA's review of modified risk products is intended to ensure that adult users have clear, science-based information about the relative harms of tobacco products, so they can make informed choices," Bret Koplow, acting director of the FDA's Center for Tobacco Products, said in a statement. "Today's decision allows these products to be marketed with a modified risk claim that informs adults who smoke about the lower risks associated with these products."
The products covered by the order include Zyn Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint and Wintergreen, each in 3-milligram and 6-milligram nicotine strengths.
"FDA's decision is an important moment for the more than 45 million legal-age nicotine consumers in America," Philip Morris U.S. CEO Stacey Kennedy said in a statement. "Today's news ensures these adults have access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer."
Philip Morris International získává přes 43 % čistých tržeb ze smoke-free produktů a dividendu dál kryje silný cash flow. Společnost vyplácí 5,88 USD na akcii při výnosu 3,13 % a zvýšila dividendu 17 let po sobě.
Philip Morris International (NYSE:PM | PM Price Prediction) is a tobacco giant in the middle of a profitable pivot, with smoke-free products now accounting for over 43% of net revenues through IQOS heat-not-burn devices and ZYN nicotine pouches. With markets nervous about a potentially hawkish Federal Reserve under Kevin Warsh, retirees want to know if this 3% yielder can keep delivering. I dug into the payout math to find out.
Dividend Snapshot Metric Value Annual Dividend $5.88 per share Dividend Yield 3.13% Consecutive Years of Increases 17 years Most Recent Increase 8.9% (September 2025) Dividend Aristocrat Status No (since 2008 spin-off) Payout Ratios Are Elevated but Covered by Smoke-Free Cash PM paid roughly $9.1 billion in dividends against $12.233 billion of operating cash flow in FY2025. On 2026 guidance for $13.5 billion in OCF and $1.4 to $1.6 billion of capex, free cash flow should land near $12 billion, comfortably above the payout.
Metric TTM Value Assessment Earnings Payout Ratio (FY25 EPS $7.54) ~78% Elevated Forward Payout (2026 guide $8.36 to $8.51) ~70% Improving FCF Payout Ratio ~76% Healthy Operating Cash Flow Coverage 1.34x Adequate Negative Equity Looks Scary, but Leverage Is on the Way Down The Swedish Match acquisition left shareholders’ equity at negative $7.3 billion, making debt-to-equity less informative here. Leverage is the key metric: management is targeting net debt to adjusted EBITDA near 2.0x by year-end 2026, supported by $5.45 billion in cash and EBITDA of $18.6 billion. Interest coverage remains comfortable given FY2025 operating income of $14.892 billion.
17 Straight Hikes and No Buybacks Competing for Cash Year Annual Dividend 2026 (run-rate) $5.88 2025 $5.64 2024 $5.20 2023 $5.14 2021 $4.90 PM has raised every year since spinning off in 2008, and importantly, no share repurchases are planned in 2025 or 2026. The dividend gets first call on cash.
Management Calls It a Progressive Dividend Policy On the Q1 2026 call, CEO Jacek Olczak stated, “We remain firmly committed to our progressive dividend policy and to returning value to shareholders as our transformation delivers sustainable long-term growth.” CFO Emmanuel added that the business is “supported by remarkable cash generation and a strong balance sheet.” Nine directors also bought stock at $169.93 on May 6, 2026.
The Verdict: Safe, With Smoke-Free Doing the Heavy Lifting Dividend Safety Rating: Safe. The payout ratio is elevated near 78% on trailing earnings, but 2026 guidance of 10.9% to 12.9% EPS growth rapidly relieves that pressure, and FCF coverage is solid. The income case holds if IQOS and ZYN keep compounding at current rates and management hits the 2.0x leverage target. I would grow cautious if combustible volume declines accelerate beyond the guided 3% or FDA action restricts ZYN. For now, the cigarette dividend is still lit.
